1. Home
  2. BANC vs NVCR Comparison

BANC vs NVCR Comparison

Compare BANC & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Banc of California Inc.

BANC

Banc of California Inc.

HOLD

Current Price

$20.09

Market Cap

3.0B

Sector

Finance

ML Signal

HOLD

Logo NovoCure Limited

NVCR

NovoCure Limited

HOLD

Current Price

$14.29

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BANC
NVCR
Founded
1941
2000
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Major Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
1.5B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
BANC
NVCR
Price
$20.09
$14.29
Analyst Decision
Strong Buy
Buy
Analyst Count
9
6
Target Price
$20.06
$28.42
AVG Volume (30 Days)
1.7M
1.5M
Earning Date
01-22-2026
10-30-2025
Dividend Yield
2.02%
N/A
EPS Growth
N/A
N/A
EPS
1.03
N/A
Revenue
$1,019,965,000.00
$642,269,000.00
Revenue This Year
$6.10
$9.75
Revenue Next Year
$10.89
$5.62
P/E Ratio
$19.29
N/A
Revenue Growth
147.22
11.17
52 Week Low
$11.52
$10.70
52 Week High
$20.17
$30.78

Technical Indicators

Market Signals
Indicator
BANC
NVCR
Relative Strength Index (RSI) 66.81 65.38
Support Level $19.11 $12.88
Resistance Level $19.77 $13.64
Average True Range (ATR) 0.38 0.50
MACD -0.07 0.08
Stochastic Oscillator 96.55 95.83

Price Performance

Historical Comparison
BANC
NVCR

About BANC Banc of California Inc.

Banc of California Inc is a financial holding company. It offers banking and financial services. Its services include banking services, lending services, and private banking services. Its deposit and banking product and service offerings include checking, savings, money market, certificates of deposit, and retirement accounts. Lending activities are focused on providing financing to California's diverse private businesses, entrepreneurs, and communities, and loans are often secured by California commercial and residential real estate. The company has one reportable segment named Commercial banking.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

Share on Social Networks: